2020
DOI: 10.4266/acc.2020.00241
|View full text |Cite
|
Sign up to set email alerts
|

Suggestions and tips regarding polymyxin B-immobilized fiber column direct hemoperfusion of neonates with sepsis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
(6 reference statements)
0
1
0
Order By: Relevance
“…Since 2011, a PMX-DHP column specialized for neonates with a priming volume of only 8 mL (Toraymyxin ® 01-R; Toray Medical Co., Tokyo, Japan) has been available in Japanese clinical settings. We have been using PMX-DHP for neonatal septic shock and have published several of our experiences [2][3][4][5][6]. Similar to the successful experience described by Mitaka et al [1] , we use PMX-DHP as long as possible, instead of the conventional duration (2 h per session [7]) when there are no adverse events and extracorporeal circulation is possible.…”
mentioning
confidence: 72%
“…Since 2011, a PMX-DHP column specialized for neonates with a priming volume of only 8 mL (Toraymyxin ® 01-R; Toray Medical Co., Tokyo, Japan) has been available in Japanese clinical settings. We have been using PMX-DHP for neonatal septic shock and have published several of our experiences [2][3][4][5][6]. Similar to the successful experience described by Mitaka et al [1] , we use PMX-DHP as long as possible, instead of the conventional duration (2 h per session [7]) when there are no adverse events and extracorporeal circulation is possible.…”
mentioning
confidence: 72%